GRANULES INDIA LIMITED
	Regd Office : 2nd Floor, 3rd Block, My Home Hub
	Madhapur, Hyderabad 500 081
	UNAUDITED FINANCIAL RESULTS
	FOR THE QUARTER  ENDED 30th JUNE, 2008
						Rs. Lakhs
	S No	Particulars	Quarter ended             30th June 2008	Quarter ended             30th June 2007	Year to date             30th June 2008	Year to date / Audited previous accounting      year ended             30th June 2007
	1	Gross sales	6,413.60	4,647.79	22,472.58	19,519.33
		Less : Excise Duty & Sales tax	242.89	181.81	1,057.93	949.23
	2	Net sales/ Income from operations	6,170.71	4,465.98	21,414.65	18,570.10
	3	Other Income	10.91	104.34	50.82	246.31
	4	Total expenditure
		a) (Increase)/decrease in stock in trade	(276.94)	553.65	(869.25)	13.23
		b) Material consumption	3,976.42	2,014.21	13,380.07	10,720.73
		c) Manufacturing expenses	452.59	426.37	1,756.58	1,588.94
		d) Employee cost	361.57	278.35	1,417.23	1,200.97
		e) Other expenditure	738.76	460.32	2,376.31	1,923.29
	5	EBIDTA (2-4)	918.31	733.08	3,353.71	3,122.94
	6	Interest and finance charges	335.55	271.01	1,196.53	1,202.85
	7	Depreciation	250.06	203.74	967.65	817.73
	8	Profit before taxation	343.61	362.67	1,240.35	1,348.67
	9	Current tax expense	39.10	41.09	126.79	43.93
	10	Deferred tax expense	30.98	52.96	199.43	283.65
	11	Fringe Benefit  Tax	3.26	2.54	11.70	9.11
	12	Net Profit	270.27	266.08	902.43	1,011.98
	13	Paid up share capital	2,005.72	2,002.36	2,005.72	2,002.36
		(face value of Rs. 10/- each)
	14	Reserves excluding Revaluation reserve				15,262.42
	15	Basic Earnings per share (Rs.)*	1.35	1.33	4.50	7.63
	16	Diluted Earnings per share (Rs.)*	1.25	1.74	4.17	6.81
	17	No. of equity shares	20,057,154	20,023,634	20,057,154	20,023,634
	18	Aggregate of Public Share holding:
		- Number of shares	13,547,423	13,670,603	13,547,423	13,670,603
		- Percentage of share holding	67.54%	68.27%	67.54%	68.27%
	* Not Annualised for quarter ending
	NOTES :
	1) The above  results were reviewed by the Audit Committee and approved by the Board at its meeting held  on
	31st July, 2008 and were subjected to limited review by Statutory Auditors.
	2) The company has not received any complaints from investors during the quarter 1st April '08 to 30th June'08
	and no complaints were pending from previous quarter.
	3) The company operates only in the segment of Pharmaceuticals.
	4) Diluted EPS includes 16,00,000 share warrants which are yet to be converted.
	5) Figures are regrouped wherever necessary.
					for and on behalf of the Board
	Place  : Hyderabad				Dr.C.Nageswara Rao
	Date   :  31.07.2008				Chairman